New CPD module to support pharmacist shared medicines list

Media Release

8 June 2020

The Pharmaceutical Society of Australia (PSA) has developed a dedicated CPD module in partnership with the Australian Digital Health Agency (ADHA), equipping pharmacists and pharmacy staff with training on clinical documentation and use of the Pharmacist Shared Medicines List (PSML).

The PSML is a new clinical document type supported by the My Health Record System and contains detailed information about medicines a patient is known to be taking.

The list includes both prescription and non-prescription medicines, including ‘over-the-counter medicines and complementary medicines such as vitamins and herbal products and can only be prepared and uploaded to a patients My Health Record by a pharmacist.

PSA National President Associate Professor Chris Freeman says the delivery of information, education and awareness for pharmacists will help ensure the successful implementation of the PSML.

“We are pleased to partner with the ADHA to produce this module and I encourage pharmacists to equip themselves on how to use the PSML,” says Associate Professor Freeman.

“As shown in our Medicine Safety: Take Care report, medication-related problems cause 250,000 hospital admissions a year and result in an annual cost of $1.4 billion.

“Pharmacists that have access to the PSML can make more informed decisions when prescribing and dispensing medicines for patients.”

The PSML builds on the capability of the current medicines information view by providing a list of medicines the patient is known to be taking at a point in time and will improve information sharing between health professionals.

More information of the CPD module can be found at: my.psa.org.au/s/training-plan/a110o000009NmIC/the-pharmacist-shared-medicines-list

Text by: The Pharmaceutical Society of Australia

Must Read

Calls for more holistic management of epilepsy

0
Researchers from the Australian Epilepsy Project (AEP) at The Florey are calling for changes to the way epilepsy is managed after a preliminary study highlighted differences...

TB funding vital